Arecor Therapeutics (AREC)

Company name:	Arecor Therapeutics Plc
EPIC:	AREC	Trading Currency:	GBX
Market Sector:	AMQ1	ISIN:	GB00BMWLM973
Market Segment:	ASQ1	Share Type:	DE
WWW Address:	http://www.arecor.com/	Description:	ORD GBP0.01
Industry Sector:	PHARMACEUTICALS & BIOTECHNOLOGY

Arecor Therapeutics Key Figures

(at previous day's close)
Market Cap.	93.25	m
Shares In Issue	27.84	m
Prev. Close	350.00
PE Ratio	-
Dividend Yield	-	%
EPS - basic	-0.27	p
Dividend PS	-	p
Dividend Cover	-
Cash Flow PS	-19.58	p
Return On Equity (ROE)	-33.26	%
Operating Margin	-599.74	%
PEG Factor	-
EPS Growth Rate	-	%
Dividends PS Growth Rate	-	%
Net Debt	-15.94	m
Gross Gearing	11.34	%
Quick Assets	20.56	m
Net Working Capital	18.30	m
Intangibles / Fixed Assets	8.38	%
Turnover PS	4.16	p
Pre-Tax Profit PS	-24.95	p
Retained Profit PS	-22.16	p
Cash PS	65.80	p
Net Cash PS	57.66	p
Net Tangible Asset Value PS *	66.53	p
Net Asset Value PS	66.64	p
Spread	30.00 (8.57%)
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Period ^†	Open	Change	%	Open Avg.	Avg. Daily Vol [m]	Total Vol [m]	VWAP
1 week	370.00	-35.00	-9.46	335.00	0.00		351.70
4 weeks	380.00	-45.00	-11.84	335.00	0.00		355.94
12 weeks	385.00	-50.00	-12.99	335.00	0.00		389.97
26 weeks	400.00	-65.00	-16.25	315.00	0.00		376.13
1 year	237.50	97.50	41.05	226.00	0.01		328.10
3 years	237.50	97.50	41.05	226.00	0.01		307.18
5 years	237.50	97.50	41.05	226.00	0.01		307.18
† periods calculated are whole weeks rather than calendar months

(Market value analysis) at previous day's close
PQ Ratio	-
PE Ratio	-
Tobin's Q Ratio	4.46
Tobin's Q Ratio (excl. intangibles)	4.46
Dividend Yield	-	%
Market-to-Book Ratio	5.03
Price-to-Pre-Tax Profit PS	-13.43
Price-to-Retained Profit PS	-15.12
Price-to-Cash Flow PS	-17.11
Price-to-Sales PS	80.52
Price-to-Net Tangible Asset Value PS	5.04
Price-to-Cash PS	5.09
Net Working Capital PS	65.73
Price Pct to Working Capital PS	5.10	%
Earnings Yield	-	%
Average PE	-
Years in average	-
PE to PE average	-	%

(Leverage Ratios)
Debt Ratio	0.56	%
Debt-to-Equity Ratio	0.01
Debt-to-Equity Ratio (excl. Intgbl)	0.01
Debt-to-Equity Market Value	0.00
Net Gearing	-76.21	%
Net Gearing (excl. Intangibles)	-76.32	%
Gross Gearing	11.34	%
Gross Gearing (excl. Intangibles)	11.35	%
Gearing Under 1 Year	10.84	%
Gearing Under 1 Year (excl. Intgbl)	10.85	%
Assets/Equity	1.13
Cash/Equity	98.74
(Liquidity Ratios)
Net Working Capital to Total Assets	87.45	%
Current Ratio	9.07
Quick Ratio (Acid Test)	9.07
Liquidity Ratio	8.08
Cash & Equiv/Current Assets	89.07	%
(Solvency Ratios)
Enterprise Value	75.04	m
CFO/Sales	-4.71
CFO/Attributable Profit	-
CFO/Assets	-0.26
CFO/Debt	-2.30
Total Debt/Equity Market Value	0.03
Total Debt/Sales	2.05
Total Debt/Pre-Tax Profit	-0.34
Total Debt	2.37	m
Total Debt/Net Current Assets	0.13	%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth	-	%
5 yr Compound Earnings Growth	-	%
10 yr Compound Earnings Growth	-	%
Earn drops > 5% in 10yrs	-

Beta (60-Mnth)	Beta (36-Mnth)
0.3327	0.3327

(Profitability Ratios)
Return On Capital Employed (ROCE)	-37.23	%
Return On Assets (ROA)	-29.49	%
Net Profit Margin	-532.73	%
Assets Turnover	0.06
Return On Equity (ROE)	-33.26	%
Return On Investment (ROI)	-33.07	%
Dividend Payout Ratio	-	%
Plowback Ratio	100.00	%
Growth from Plowback Ratio	-	%
Net Income Of Revenues	-532.73	%
(Asset Utilisation Multiples)
Shareholders Equity Turnover	0.06
Fixed Assets Turnover	3.23
Current Assets Turnover	0.06
Net Working Capital Turnover
Inventory Turnover	-
(Other Operating Ratios)
Total Assets-to-Sales	18.07
Debtors-to-Sales	194.04	%
Debt Collection Period	708.25	Days

Sorry No Data Available

Broker infomation is not available for this class of stock.